The Parenteral Drug Association (PDA), the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community, announced that 31 of its Training and Research Institute (TRI) courses are now listed with the US General Services Administration (GSA) under a Federal Supply Schedule contract.

The 31 courses will be included on the GSA Advantage, GSA’s online shopping and ordering system https://www.gsaadvantage.gov/advantage/main/start_page.do). This will improve the visibility of these PDA TRI courses to federal officials and make it easier for them to participate. Over the years, PDA TRI has conducted numerous training courses specifically designed for officials at the US Food and Drug Administration. In addition, FDA officials have participated in TRI’s regular course offerings.

“By adding 31 courses to the GSA Federal Supply Schedule, employees of the US Federal Government will have an easier time participating in the unique,  world class training courses in the PDA TRI facilities and lecture courses,” says PDA president Richard Johnson.

The courses are listed under Special Item Numbers (SINs) 874-4: Training Services. They are:

An Introduction to the Advanced Molecular Methods for Virus Detection
 An Introduction to Visual Inspection
 Aseptic Processing for Senior Management
 Aseptic Processing Training Program
 Biosimilars - Understanding the Challenges of Meeting 'Similarity'
 CMC Regulatory Requirements in Drug Applications
 Evaluation, Validation and Implementation of Alternative and Rapid Microbiological Testing Methods
 Filters and Filtration in the Biopharmaceutical Industry – Basics Course
 Filters and Filtration in the Biopharmaceutical Industry – Basics Course and Advanced Course
 Filters and Filtration in the
 Biopharmaceutical Industry – Advanced Course
 Fundamentals of an Environmental Monitoring Program
 Fundamentals of Aseptic Processing
 Fundamentals of Cleaning and Disinfectant Programs for Aseptic Manufacturing Facilities
 Fundamentals of Lyophilization
 Fundamentals of Lyophilization and Validation of Lyophilization
 GMPs for Manufacturers of Sterile and/or Biotechnology Products
 Implementation of Quality Risk Management for Commercial Pharmaceutical and Biotechnology Manufacturing Operations
 Implementing Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations: Case Studies in the Manufacturing of Biotechnological Bulk Drug Substances
 Implementing Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations: Case Studies in the Packaging and Labeling of Drug Products
 Implementing Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations: Case Studies in the Manufacturing of Pharmaceutical Drug Products
 Investigating Microbial Data Deviations
 Microbiological Quality of Raw Materials and Components
 Microbiological Risk Assessment of a Pharmaceutical Manufacturing Process
 Preparation of Virus Spikes Used for Virus Clearance Studies and Virus Filtration
 Quality Systems for Aseptic Processing
 Risk-Based Qualification of Sterile Drug Product Manufacturing Systems
 Single-Use Systems for the Manufacturing of Parenteral Products
 Validation of Biotechnology-related Cleaning Processes
 Validation of Dry Heat Processes Used for Depryogenation And Sterilization
 Validation of Lyophilization
 Virus Contamination in Biomanufacuring: Risk Mitigation, Preparedness and Response

PDA Training and Research Institute (TRI) has established itself as the leading global provider of education, training and applied research opportunities in pharmaceutical sciences and associated technologies. TRI offers courses for professionals involved in developing and manufacturing quality pharmaceutical and biopharmaceutical products, targeting individuals employed in industry, government and academia worldwide.